A 73-year-old man was referred to us for evaluation of extensive nasal crusting and progressive erosion of the nasal midline structures. Clinical examination suggested that the patient had a T-cell lymphoma, a suspicion that was confirmed on immunohistochemical analysis. The patient was treated with combination chemo-and radiotherapy and exhibited a marked response. At the 14monthfollowup, he remained disease-free.
Introduction
Nasal T-cell lymphomas are aggressive, locally destructive midfacial necrotizing lesions. It is now recognized that the vast majority of cases oflethal midline granuloma represent nasal T-cell Iymphomas.I' In this article, we describe one such case in an elderly man, and we briefly review some of the more salient features of the diagnosis of this disease.
Case report
A white 73-year-old man was evaluated at an outside institution for an 18-month history of nasal obstruction and chronic rhinorrhea. He was found to have nasal polyposis and a septal perforation, and he underwent endoscopic sinus surgery with polypectomy and septal button placement. Postoperatively, he failed to improve. He exhibited extensive nasal crusting and progressive erosion of the nasal midline structures. Results of biopsy analysis of the involved nasal mucosa were inconclusive. He was referred to us for further evaluation.
Our examination revealed an extensive amount of friable, granular tissue along the floor of the nose and lateral The patient was treated with 5,000 cGy of externalbeam radiation, followed by six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy. He demonstrated a marked clinical response.
On followup examination at 14 months, the oronasal fistula had closed. Nasal examination revealed a foreshortening of the columella secondary to fibrosis with contracture ( figure 3) . The patient developed osteoradionecrosis of the hard palate at the site of his previous ulceration because of inadequate soft-tissue coverage ( figure 4 ). There was no evidence oflocal recurrence or residual disease.
Discussion
Nonspecific nasal symptoms often predate the appearance of mucosal ulceration and tissue necrosis by 1 year or more.?" The ambiguous nature of these symptoms can result in a delay in diagnosis. The initial symptom in most cases is nasal obstruction; purulent rhinorrhea is the second most common sign. 3 ,6,7 The nasal mucosa is usually pale, friable, and granular and is often accompanied by purulence or crusting. Oronasal fistulas frequently occur as a result of mucosal ulceration and palate necrosis.' Nasal septal perforation has been reported in 40% of cases of nasal Tvcell Iymphoma," Systemic symptoms such as fever and weight loss are not typically noted except in advanced cases.t" Systemic dissemination at the time of the initial evaluation is seen in fewer than 10% of patients. When it is present, it usually occurs in extranodal sites.P Histologically, representative biopsies demonstrate a mixed cellular infiltrate, which consists of plasma cells, eosinophils, histiocytes, atypical lymphoid cells, neutrophils, and macrophages. Angiocentricity and angioinvasion are present, along with the resultant marked tissue Volume 80, Number 7
ENT-Ear, Nose & Throat Journal • July 2001
For more information Circle 114 on Reader Service Card Figure 3 . Fourteen months following the completion ofcombination chemo-and radiotherapy, the patient manifests aforeshortening of the nasal columella secondary to fibrosis and contracture, but no evidence ofresidual or recurrent disease. ischemia and necrosis. The diagnosis depends on the identification of atypical lymphoid cells. Because of extensive necrosis and reactive inflammatory changes, superficial biopsies are often inconclusive." Immunohistochemistry and flow cytometry typically demonstrate the presence of the T-cell-associated markers CD2, CD7, CD45RO, and CD43. 6 The lymphoma cells express the natural killer cell marker CD56, but not the natural killer cell markers CD 16 and CD57. I Evidence of Epstein-Barr virus has been found in all nasal T-cell lymphomas to date, suggesting that the virus plays a causative role in the pathogenesis of these lesions. I • 3 ,6.7 Phenotypically, nasal lymphomas differ from lymphomas that arise in the paranasal sinuses and in Waldeyer's ring; the latter tumors are predominantly B cell lymphomas. 1.2,5 Nasal T-cell lymphomas respond well to local radiation therapy. Even so, death from this disease occurs in 50% of patients as a result ofdistant extranodal spread or relapses that occur outside the treatment field. 1,3.6,7 Treatment with chemotherapy alone as a primary modality has not been shown to confer a survival advantage.v? The use of chemotherapy for salvage following radiation therapy has been disappointing to date,":" Multiagent chemotherapy in combination with radiation therapy as the initial treatment approach is now recommended in an attempt to control the primary lesion as well as to prevent early dissemination.1.10 460 Figure 4 . Osteoradionecrosis ofthe maxilla is present at the site of the previous ulceration, but there is no evidence of residual disease.
